Educational Strategies for Advanced Kidney Disease
(THRiVE Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It seems focused on educational strategies rather than medication changes.
Research shows that educational and empowerment programs can improve the quality of life for kidney patients by helping them manage their own care better. Motivational interviewing, a part of this treatment, has been effective in encouraging behavior change and improving patient outcomes in kidney disease management.
12345The educational strategies, including motivational interviewing and tailored education, have been used safely in various health conditions, such as cancer and kidney disease, to improve patient understanding and management of their health.
36789This treatment is unique because it combines educational materials and motivational interviewing to help patients with advanced kidney disease understand their options, including conservative management and advance care planning, which are often overlooked in standard care. It focuses on culturally and linguistically tailored education, making it more accessible and relevant to diverse patient populations.
1391011Eligibility Criteria
This trial is for adults over 18 with advanced chronic kidney disease who've discussed hemodialysis with their doctor, visited a nephrologist in the last 18 months, and have specific lab results indicating severe kidney function decline. It's not for those already planning different kidney failure treatments or who can't use the educational materials due to cognitive or visual impairments.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Education Phase
Participants receive educational materials and support based on their assigned group: Education, Education-Plus, or Usual Care.
Follow-up
Participants are monitored for outcomes such as vascular access evaluation and decision self-efficacy.